VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
Fidelity National Information Services, Inc. vs Gilead Sciences, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Fidelity National Information Services, Inc.
FIS · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Fidelity National Information Services, Inc.'s moat claims, evidence, and risks.
View FIS analysisGilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisComparison highlights
- Moat score gap: Gilead Sciences, Inc. leads (74 / 100 vs 65 / 100 for Fidelity National Information Services, Inc.).
- Segment focus: Fidelity National Information Services, Inc. has 2 segments (68.1% in Banking Solutions); Gilead Sciences, Inc. has 5 segments (68.5% in HIV).
- Moat breadth: Fidelity National Information Services, Inc. has 6 moat types across 3 domains; Gilead Sciences, Inc. has 8 across 3.
Primary market context
Fidelity National Information Services, Inc.
Banking Solutions
Core banking platforms and bank transaction processing software/services
Global
Banks, credit unions, commercial lenders, and other institutions
Software/platform provider and outsourced processor
68.1%
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Side-by-side metrics
Moat coverage
Shared moat types
Fidelity National Information Services, Inc. strengths
Gilead Sciences, Inc. strengths
Segment mix
Fidelity National Information Services, Inc. segments
Full profile >Banking Solutions
Oligopoly
Capital Market Solutions
Competitive
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.